Experience

Woodstock Sterile Solutions

• United States
• Pharmaceutical Manufacturing
• 100 - 200 Employee

• Chief Scientific Officer

  • Jul 2022 - Present

  Greater Chicago Area SK Capital (Private Equity) acquired Blow Fill Seal business from Catalent in 2021 resulting in the creation of Woodstock Sterile Solutions. Leading CDMO focused on sterile ophthalmic and respiratory dosage forms. In addition, capabilities for diagnostics and oral liquids. Responsible for - New Product Development, Project Management, Development Services, Tech Transfer, New Business Development, and Quality Lab Expansion Services



Viatris

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Global Dermatologics R&D Scientific Affairs

  • Nov 2020 - Jul 2022

  San Antonio, Texas Metropolitan Area Mylan and Upjohn merged to create Viatris in Nov 2020 Global role leading R&D/Technical Operation for 5 sites globally - • DPT San Antonio, Mylan Technologies (WV and Vermont), Mylan Sugarland, Viatris Merignac France, and Confienza Italy Semisolid/Liquid (Oral and Topical), Transdermal, Aerosol, Nasal Spray, Oral Thin-film R&D, Regulatory Science and Technical Services DPT/CDMO development support and services



The University of Texas at San Antonio

• United States
• Higher Education
• 700 & Above Employee

• Scientific Advisory Panel (College of Sciences)

  • Jan 2012 - Jul 2022



Mylan

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Head of Global Dermatological R&D Scientific Affairs

  • Jun 2016 - Nov 2020

  San Antonio, Texas Area DPT Labs (Renaissance acquisition holdings - Private Equity) acquired by Mylan in June 2016 Responsibilities - Mylan Global Semisolid, Liquid, Aerosol, Nasal Spray, and Transdermal R&D pipeline R&D, Regulatory Science, Clinical strategy and Technical Operations DPT/CDMO customer pipeline and service Management of R&D centers of excellence State of art R&D facilities and 150+ scientist/staff



DPT Laboratories

• United States
• Pharmaceutical Manufacturing
• 300 - 400 Employee

• Sr. Vice President/VP, R&D

  • Jan 2012 - Jun 2016

  San Antonio, Texas Area DPT labs - Acquired in 2012 by Private Equity “Renaissance Acquisition Holdings“ (RoundTable Partners) Member of Sr. Management Team. Leading R&D Center for Excellence and overall R&D responsibility for all sites (Subsidiary of Renaissance Acquisition Holdings, Private Equity) - DPT San Antonio TX - Semisolid/Liquid, Topical, Foam, Implant, Nasal Spray DPT Lakewood NJ - Injectable (SVP), Nasal, Opthalmic Confab Montreal Canada - Oral Solids, Semi-solids, Suppository… Show more DPT labs - Acquired in 2012 by Private Equity “Renaissance Acquisition Holdings“ (RoundTable Partners) Member of Sr. Management Team. Leading R&D Center for Excellence and overall R&D responsibility for all sites (Subsidiary of Renaissance Acquisition Holdings, Private Equity) - DPT San Antonio TX - Semisolid/Liquid, Topical, Foam, Implant, Nasal Spray DPT Lakewood NJ - Injectable (SVP), Nasal, Opthalmic Confab Montreal Canada - Oral Solids, Semi-solids, Suppository Responsibilities include: CDMO and internal proprietary development R&D strategy and goals Pipeline selection and new product evaluation Pre-form/Formulation Development Analytical Development and Validation Process Development and Optimization Tech Transfer Regulatory Affairs Clinical Operations Program Management FDA filings and Interaction P&L Management of CDMO Development Services - Project Management System - Client Interaction - Financials Show less



Nycomed/Fougera Pharmaceuticals Inc. - A Sandoz Company

• Vice President, R&D and Technical Operations

  • Jan 2011 - Dec 2011

  Long Island, NY Lead R&D drug development for new/generic drugs and Technical Operation for Semi-solid, Liquid, Opthalmic, Otic, Nasal Sprays and Aerosol. Acquired by Sandoz in 2011. Responsibilities Include: New product selection and pipeline strategy Formulation Development Analytical Development and Validation Process Development and Optimization Tech Transfer Technical Operations Package Engineering FDA interaction CMC strategy FDA remediation CAPA and Root Cause… Show more Lead R&D drug development for new/generic drugs and Technical Operation for Semi-solid, Liquid, Opthalmic, Otic, Nasal Sprays and Aerosol. Acquired by Sandoz in 2011. Responsibilities Include: New product selection and pipeline strategy Formulation Development Analytical Development and Validation Process Development and Optimization Tech Transfer Technical Operations Package Engineering FDA interaction CMC strategy FDA remediation CAPA and Root Cause Analysis

• Sr. Director, Product and Process Development

  • Jun 2006 - Dec 2010

  Long Island, NY



Medicis

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Director, Product Development

  • Apr 2004 - Jun 2006

  Scottsdale, AZ Directed Product Development activities for variety of dosage forms - Oral solids (ER, SR, Immediate), Semi-solid and Liquid, Sprays, Aerosol, Microsphere, and Pads/films. Formulation Development and Selection Analytical Development and Validation Process Development and Scale-up Participated in the Regulatory Strategy CMC Preparation CRO Management Part of Quality Improvement Team Part of the Team for development and Launch of: Vanos Cream Solodyn Extended… Show more Directed Product Development activities for variety of dosage forms - Oral solids (ER, SR, Immediate), Semi-solid and Liquid, Sprays, Aerosol, Microsphere, and Pads/films. Formulation Development and Selection Analytical Development and Validation Process Development and Scale-up Participated in the Regulatory Strategy CMC Preparation CRO Management Part of Quality Improvement Team Part of the Team for development and Launch of: Vanos Cream Solodyn Extended Release Tablets Ziana Gel (combination product) Orapred Suspension (taste masking technology) Triaz Pads and Plexion Cloths

• Manager, Formulation and Method Development

  • Jan 2003 - Mar 2004

  Phoenix, Arizona Area



Mylan

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Pharmaceutical Product Development

  • Jan 1998 - Dec 2002

  Pre-formulation, Formulation, Method Development and Process Development of Topicals and Transdermals.